We use cookies to so our web site can function correctly. By Clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed. To find out more visit the cookies section of our privacy policy.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

About CAR T-cell therapy

CAR T-cell therapy is a type of adoptive cell therapy, custom made for each patient using their own T-cells. Our T-cells play a vital role in our immune system, orchestrating the immune response in our bodies by killing cells that have become infected by pathogens (bacteria or germs capable of causing disease).  

On the surface of every cancer cell, there are specific antigens relating to that type of cancer. These are foreign toxins that normally induce an immune response within our body. However, sometimes our T-cell lymphocytes that search for infections stop recognising antigens as foreign and no longer destroy them, which is how cancer develops.  In CAR T-cell therapy, these genetically modified T-cells are designed to recognise and eradicate specific antigens on tumour cells.  

CAR T-cell therapy is the latest breakthrough in immunotherapy treatment and can be used to treat some blood cancers that have not responded to conventional chemotherapy.


At HCA Healthcare UK, we are committed to providing the very best care and access to emerging therapies as soon as they are available. We will be one of the first JACIE accredited private providers in the UK to offer the latest CAR T-cell therapy.

To see how CAR T-cell therapy works, watch our video.

CAR T-cell therapy, a novel type of immunotherapy, is designed to strengthen and harness the immune system's inherent cancer-eliminating powers and remove its disguise.
Patient Car Tcell diagram

What is CAR T-cell therapy?

CAR T-cell therapy involves the adoptive transfer of T-cells that have been genetically modified with a chimeric antigen receptor (CAR) to target a tumour. CAR T-cells are intended to provide immediate and specific activity against tumour cells that contain the antigen to which the CAR is aimed.


Early data outcomes from this exciting new treatment have so far shown very promising results for many patients.   


Whilst CAR T-cell therapy is an exciting step change in blood cancer treatment, at this stage it's not suitable for all patients. Our leading MDTs will ensure every individual patient's case is reviewed, in order to ensure patients that can benefit from this treatment can access it at a specialist centre.

Who is CAR T-cell therapy suitable for?

CAR T-cell therapy is used to treat patients who have not responded to standard first and second line treatment. Initially we will be accepting referrals for patients over 18 with: diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma and transformed follicular lymphoma. We are preparing to accept referrals for other types of blood cancers soon.

  • check icon

    Acute lymphoblastic leukaemia

  • check icon

    Transformed follicular lymphoma

  • check icon

    Primary mediastinal large b-cell lymphoma

  • check icon

    Diffuse large B-cell lymphoma

Our CAR T-cell therapy consultants

Consultant

Dr Kirit Ardeshna thumbnail

Kirit Ardeshna

Consultant Haematologist

Specialties

Haematology: Lymphoma

Works at

HCA UK at University College Hospital

London Bridge Hospital

Sarah Cannon Research Institute

The Harley Street Clinic

The Wellington Hospital

LOC at 95 Harley Street

LOC in HCA UK at University College Hospital

LOC at Platinum Medical Centre

LOC at London Bridge Hospital

Consultant

Dr Panagiotis Kottaridis thumbnail

Panagiotis Kottaridis

Consultant Haematologist

Specialties

Haematology: Leukaemia,Lymphoma

Works at

The Princess Grace Hospital

The Harley Street Clinic Diagnostic Centre

HCA UK at University College Hospital

The Wellington Hospital

London Digestive Centre

LOC at 95 Harley Street

LOC at Platinum Medical Centre

LOC in HCA UK at University College Hospital

Consultant

Professor Stephen Mackinnon thumbnail

Stephen Mackinnon

Consultant Haematologist

Specialties

Haematology: Leukaemia,Myeloma,Lymphoma

Works at

HCA UK at University College Hospital

LOC - Leaders in Oncology Care

LOC at 95 Harley Street

LOC in HCA UK at University College Hospital

Consultant

Christopher Mcnamara thumbnail

Christopher McNamara

Consultant Haematologist

Specialties

Haematology: Lymphoma

Works at

HCA UK at University College Hospital

LOC - Leaders in Oncology Care

The Harley Street Clinic Diagnostic Centre

The Princess Grace Hospital

London Digestive Centre

The Harley Street Clinic

London Bridge Hospital

The Wellington Hospital

LOC at 95 Harley Street

LOC at Platinum Medical Centre

LOC in HCA UK at University College Hospital

A collaborative approach to patient care

We work with some of the UK’s leading haematology consultants and are in a unique position to bring together multidisciplinary teams (MDTs) from renowned teaching hospitals including: University College London Hospital, Imperial College, Guy’s and St Thomas’ Hospital, King’s college Hospital, The Royal Marsden, St George’s, St Bartholomews’s and The Christie.

These MDTs of leading specialists come together to discuss treatment options and ensure the best treatment pathway is always delivered to each patient.  
CAR T-Cell Quality

"Through our unrelenting commitment, expertise and dedication we deliver personalised care to each of our patients, and are changing the way we treat blood cancer for the better."

 

Professor Stephen McKinnon

Consultant Haematologist, HCA UK at University College Hospital 

 

JACIE logo

A comprehensive haematology service

At HCA Healthcare UK we have developed comprehensive haematology services including dedicated JACIE-ISCT accredited haematopoietic stem cell transplant units.  We work in partnership with some of the UK’s most prestigious university teaching hospitals and are one of the only private providers in the UK to offer these complex haematology services.

All of our hospitals that provide these complex haematology services have achieved the highest rating of ‘Outstanding’ from the CQC.
 

Our CAR T-cell centres

CAR T-cell therapy is a complex treatment and will only be provided at a small number of sites in the UK. Our partnerships mean we will be one of the first JACIE accredited centres in the UK to offer CAR T-cell therapy under a commercial license. CAR T-cell therapy will firstly be available at HCA UK at University College Hospital, followed by The Christie Private Care later this year.

Harley Street Clinic at UCH Facility

HCA UK at University College Hospital

Christie Private Care Hero

The Christie Private Care

(Service in development)

Contact us about CAR T-cell therapy

Please get in touch if you would like to know more information about CAR T-cell therapy, including the treatment process, suitability to receive therapy, referral from your consultant for therapy and the cost of treatment. 

Please be aware we are currently only accepting CAR T-cell therapy referrals for patients over 18 with: diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma and transformed follicular lymphoma.

This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.
back to top